-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Science and Technology Daily (Reporter Liu Zhiwei, Correspondent Du Weiwei, Zou Yaqin, Wang Jianying) On June 25, the reporter learned from Wuhan University People’s Hospital that the “Tumor Metabolic Immunity” team of the hospital found that a drug can make the body “pretend” to eat less.
Earlier studies have found that "eat less" can enhance the body's immune surveillance, improve the body's ability to recognize, kill, and promptly remove mutant cells in the body, and it can also significantly improve the efficacy of immunogenic chemotherapeutics
The team found that a powerful autophagy inducer "picropodophyllin", by inhibiting the selective insulin-like growth factor 1 receptor (IGF1R), becomes a new calorie restriction mimic, which can improve the body's tumor response The role of immune surveillance, while increasing tumor immunogenicity, further activate the body's anti-tumor immune response ability
The research team therefore proposed that IGF1R may constitute a new drug treatment target
Related research papers were published in the famous international journal of tumor immunity "Journal of Cancer Immunotherapy", and were completed by Dr.